DRAFT
Patent Lens > Technology Landscapes > Agrobacterium-mediated transformation of plants

Brassica - Patent Assigned to AgrEvo Canada Inc. (now Bayer Crop Science)

Specific Patent Information

Patent Number

Title, Independent Claims and Summary of Claims

Assignee

US 6316694

  • Earliest priority - 17 March 1995
  • Filed - 14 November 1997
  • Granted - 13 November 2001
  • Expected expiry - 14 March 2016

Title - Transformed embryogenic microspores for the generation of fertile homozygous plants

Claim 1

A method for producing a stably transformed Brassica embryogenic microspore, capable of leading to a non-chimeric transformed haploid or doubled haploid embryo which develops into a fertile homozygous Brassica plant within one generation, said process comprising the following steps:
a. infecting an embryogenic microspore with Agrobacteria, which contain a plasmid carrying a gene of interest under regulatory control of initiation and termination signals bordered by at least one T-DNA border, and
b. washing out and killing the Agrobacteria after co-cultivation using mucolytic enzymes, thereby producing a stably transformed Brassica embryogenic microspore.

Claim 2

A method for producing a non-chimeric Brassica plant, containing a foreign DNA stably incorporated into its genome, said method comprising:
a. co-cultivating a Brassica embryogenic microspore with Agrobacteria which contains a plasmid carrying a gene of interest under regulatory control of initiation and termination signals;
b. washing out and killing the Agrobacteria after co-cultivation using mucolytic enzymes; and
c. regenerating a non-chimeric haploid or doubled haploid Brassica embryo from said microspore, wherein the embryo contains said gene of interest stably integrated into its genome, thereby producing a non-chimeric Brassica plant.

This patent discloses a method to generate transgenic plants from the Brassica family by using microspores as a target tissue for Agrobacterium carrying a gene of interest. After infection bacteria are eliminated by treatment with mucolytic enzymes. Microspores are further cultivated to produce haploid or doubled haploid embryos from which fully regenerated transgenic plants are obtained.

AgrEvo Canada Inc. (now Bayer Crop Science)

Remarks
  1. Claims of other granted national phase entries of the corresponding PCT application for US 6316694 (WO 1996/29419)  in Australia (AU 710201) and China (CN 1110562) are not limited to plants from the Brassica family.
  2. National phase entry of WO 1996/29419 in Canada (CA 2215763) is pending.
  3. Nationall phase entry of WO 1996/29419 n Europe (EP 737748) is deemed to be withdrawn on 6 September 2000.

Note: Patent information on this page was last updated on 13 March 2006.

The information contained in this page was believed to be correct at the time it was collated. New patents and patent applications, altered status of patents, and case law may have resulted in changes in the landscape. CAMBIA makes no warranty that it is correct or up to date at this time and accepts no liability for any use that might be made of it. Corrections or updates to the information are welcome. Please send an email to info@bios.net.

Comments (0)